Navigation Links
SNM/Nihon Medi-Physics sponsor new fellowship program for Japanese physicians
Date:11/8/2007

RESTON, Va.SNM, the worlds largest molecular imaging and nuclear medicine society, recently announced a new, two-year $24,000 fellowship program in the United States for Japanese physicians in the early stages of their career.

The SNM Wagner-Torizuka Fellowship will advance fellows research and clinical experience, as well as facilitate professional development, so young Japanese physicians can make significant contributions to the field of molecular imaging and nuclear medicine, said SNM President Alexander J. McEwan. With this new program, SNM continues its long-time tradition of promotingand expandingthe discovery of new science and the creation of new techniques and technologies, added the professor and chair of the Department of Oncology, Faculty of Medicine, at the University of Alberta, and director of oncologic imaging at Cross Cancer Institute in Edmonton, Canada. SNM is especially grateful to Nihon Medi-Physics, a Japanese diagnostic nuclear medicine firm, and SNM members Henry N. Wagner Jr. and Kanji Torizuka for sponsoring the fellowship, said McEwan. This fellowship encourages Japanese physicians to enhance international research and clinical collaboration with their American colleagues in molecular imaging and nuclear medicine and enhances cooperation between SNM and the Japanese Society of Nuclear Medicine (JSNM), he added.

For almost half a century, Japanese physicians and scientists have studied nuclear medicine in the United States. Scores of them founded and now head departments of nuclear medicine and radiology in Japan, said Wagner, professor emeritus of medicine and radiology at Johns Hopkins Medical Institutions, Baltimore, Md. This fellowship is a step toward ensuring that this outstanding relationship will continue far into the future of this exciting, new, revolutionary specialty of molecular imaging, he added. The fellowship will help assist Japanese physicians in becoming the new leaders of molecular imaging and nuclear medicine in cardiology, oncology, neurology, radiology and other specialties, said Wagner.

This program will greatly contribute to the further progress of molecular imaging and nuclear medicine in Japan, noted Torizuka, emeritus professor of Kyoto University and Fukui Medical University. Young Japanese physicians will have invaluable experiences in the United States through this wonderful program. They can then lead the exciting new era of molecular imaging and nuclear medicine in Japan, maintaining collaboration and friendship with colleagues in the United States, he added.

Eligible recipients must be permanent residents of Japan, receiving their Japanese medical license within the past 15 years. To learn more, visit SNM's Web site at http:www.snm.org/fellowships or contact Nicole Kern, SNM program manager, via e-mail at nkern@snm.org or by phone at (703) 652-6795.


'/>"/>

Contact: Maryann Verrillo
mverrillo@snm.org
703-652-6773
Society of Nuclear Medicine
Source:Eurekalert

Related medicine news :

1. TriWest Sponsors Congressional Medal of Honor Convention
2. Tennessee Faith Leaders Call on Reps. Gordon & Blackburn to Co-sponsor Legislation to Protect Kids from Tobacco
3. West Coast Bank Will Sponsor the Doernbecher Freestyle on September 22, 2007
4. PowerBar Issues Open Call for 2008-2009 PowerBar Team Elite(TM) Athlete Sponsorship Program
5. Business Executives Discuss National Health Care Reform at Conference Sponsored by The Century Foundation, with Support from The Commonwealth Fund, and AARP
6. Psychemedics Corporation Joins Accenture in Co-Sponsoring Innovative Chief Talent Officer Book
7. AABB and Fenwal Sponsor Third Annual Blood Collectors Week
8. Sponsor of Presidential Health Care Forum Has a $4 Billion Conflict of Interest: Kucinich
9. Philadelphia Insurance Companies to Sponsor the 2007 Parkway Run/Walk
10. Morris Animal Foundation 2008 Sponsorship Guide Available, Details Current Animal Health Studies
11. Congressional Support Grows for FDA Regulation of Tobacco: Bill Now Sponsored by 55 Senators, 200 Representatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... , ... January 18, 2017 , ... ... asset protection and financial planning services to families and business owners in the ... aimed at supporting children with developmental disabilities. , The Lakemary Center is a ...
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... ... communications company, launched a new website for its Center for Biosimilars, announced Michael ... include the latest developments in the field of biosimilars through thought leader interaction ...
(Date:1/18/2017)... ... January 18, 2017 , ... Floundering on New Year’s resolutions? Need an excuse ... for a reset. The U.S. Apple Association agrees and recommends starting each day ... that contribute to heart disease. , The U.S. Apple Association – which represents apple ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... difference. Eden Activewear is a stand-out company for several differences from other mainstream ... only manufacture on demand, this is called 'Agile' manufacturing - http://www.leanproduction.com/agile-manufacturing.html . ...
(Date:1/17/2017)... ... January 17, 2017 , ... SunView Software’s Service Smart Technology has ... the Year. , Each year, Pink Elephant recognizes a new product or ... address a specific business problem or opportunity. The award highlights original innovations that were ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... Jan. 18, 2017   Spotlight Innovation Inc. ... Therapeutics plans, in the second quarter of 2017, ... roll-on intended to provide relief from chronic pain, ... analgesics. It was developed under a licensing agreement ... products derived from snake venom. Additionally, Caretta Therapeutics ...
(Date:1/18/2017)... 2017  Kratom leaves, from a South East ... used to prepare tea-like beverages and commercially manufactured ... annually to increase alertness, enhance well-being and occupational ... aches and pains. PinneyAssociates, review of the scientific ... FDA and DEA in determining the most appropriate ...
(Date:1/18/2017)... , Jan. 18, 2017  Dermata Therapeutics, LLC, ... to treat a variety of dermatological diseases, announces ... DMT210, in a Phase 2 acne rosacea study. ... downregulate the proinflammatory cytokines in the skin responsible ... rosacea. This clinical trial, DMT210-003, ...
Breaking Medicine Technology: